Whilst these medications share a similar mechanism of action and side effect profile, individual tolerance can vary
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
The no-return policy Once a pen has been stored at room temperature, do not return it to the refrigerator
Researchers must continue to explore the multifaceted effects of GLP-1R agonists across organ systems, investigate long-term safety and efficacy, and uncover genetic and environmental factors that influence therapeutic response
It helps control hunger, slow gastric emptying, and enhance insulin sensitivity, leading to a prolonged feeling of fullness, reduced food intake, and subsequent weight loss
